Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 12/20 | 0.59 |
| ▸ | CA2 | P00918 | 12/20 | 0.59 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA4 | P22748 | 4/20 | 0.59 |
| ▸ | CA6 | P23280 | 4/20 | 0.59 |
| ▸ | CA5A | P35218 | 4/20 | 0.59 |
| ▸ | CA7 | P43166 | 4/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.59 |
| ▸ | APEX1 | P27695 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clofenamide SCHEMBL30748198 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL27524784 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL28383730 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL28282642 | 0.91 | CA1 (0.50) | CA1CA2CA9CA12CA4 | |
| SCHEMBL17478768 | 0.88 | CA2 (0.55) | CA1CA2CA9CA12CA4 | |
| SCHEMBL2980221 | 0.88 | CA1 (0.50) | CA1CA2CA9CA12CA4 | |
| SCHEMBL11009995 | 0.86 | LMNA (0.51) | CA1CA2CA9CA12CA4 | |
| SCHEMBL11010701 | 0.83 | CA1 (0.46) | CA1CA2CA9CA12CA4 | |
| SCHEMBL793608 | 0.82 | CA2 (0.69) | CA1CA2CA9CA12CA4 | |
| SCHEMBL25088037 | 0.81 | CA2 (0.53) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2132 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075410-A | Dry powder composition for intranasal delivery | — | 2026-05-26 | — | — | CN | claimed |
| US-20250057876-A1 | METHODS FOR TREATING AND/OR PREVENTING LYMPHANGIOGENESIS-ASSOCIATED DISEASES BY USING GOLD NANOCLUSTERS | GOLDRED NANOBIOTECH CO., LTD. (TW) | 2025-02-20 | — | — | US | claimed |
| US-20230381161-A1 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | The George Institute for Global Health (AU) | 2023-11-30 | — | — | US | claimed |
| CN-116660426-B | Method for rapidly determining various pesticide veterinary drug residues in animal-derived food and application | 山东杰诺检测服务有限公司 | 2023-10-20 | — | — | CN | claimed |
| WO-2023183932-A2 | MONOBODIES BINDING TO INTERCELLULAR ADHESION MOLECULE 2 (ICAM-2) | NEW YORK UNIVERSITY (US) | 2023-09-28 | — | — | WO | claimed |
| CN-116603066-A | Composition for treating hypertension | 乔治全球健康研究院 | 2023-08-18 | — | — | CN | claimed |
| CN-116327958-A | Composition for treating hypertension | 乔治全球健康研究院 | 2023-06-27 | — | — | CN | claimed |
| US-20230134747-A1 | COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER | STALICLA SA (CH) | 2023-05-04 | — | — | US | claimed |
| US-20230125076-A1 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | The George Institute for Global Health (AU) | 2023-04-27 | — | — | US | claimed |
| CN-115811974-A | Compositions for treating autism spectrum disorders | 斯塔利克拉股份有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| CN-1258254-A | container for a transport container | A & R INTERMODAL CORP (US) | 2000-06-28 | — | — | CN | claimed |
| EP-0973656-A1 | A VESSEL FOR A SHIPPING CONTAINER | Bedeker, James E. (US) | 2000-01-26 | — | — | EP | claimed |
| WO-1998045139-A1 | A VESSEL FOR A SHIPPING CONTAINER | BEDEKER JAMES E (US) | 1998-10-15 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| US-4855289-A | Combination of two active substances | WESTER PER O (SE) | 1989-08-08 | — | — | US | claimed |